Zoetis | ZTS - Gross Profit On Sales


Zoetis reported $1.76B in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Align Technology USD 757.43M 20.84M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Charles River Laboratories USD 348.78M 69.47M Jun/2026
Coherus Biosciences USD 8.7M 853K Dec/2025
Dentsply International USD 493M 66M Jun/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
Henry Schein USD 1.03B 39M Jun/2026
Idexx Laboratories USD 779.09M 56.35M Jun/2026
Illumina USD 770M 49M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Laboratory Of America USD 1.11B 98.2M Jun/2026
Merck USD 12.09B 1.24B Mar/2026
Neogen USD 99M 7.7M Dec/2025
Pacira USD 133.91M 7.27M Jun/2026
Perrigo USD 313.9M 11.6M Jun/2026
Pfizer USD -248M 11.29B Jun/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Sanofi EUR 8.71B 602M Jun/2026
Sanofi EUR 8.11B 343M Mar/2026
Zoetis USD 1.76B 140M Jun/2026